Hyperbaric oxygen therapy tested for post-covid conditions
High-dose pressurized oxygen can stress out old immune cells, leaving behind a younger, better functioning immune system. It helped with acute COVID, and now Anders Kjellberg is testing the method for post-covid as well.
Hyperbaric oxygen therapy, giving patients 100 percent oxygen at a pressure corresponding to 10-20 meters below sea level, has been around for almost 100 years. But the method lacks modern evidence from clinical studies, which also means that there is a lack of knowledge about dosage, all patients receive the same dose.
"When I started my research, I wanted to find out how the treatment should be dosed to different patients," says ...












